View all content in this specialty

Abstract | April 6, 2022


Melanoma is a tumor produced by the malignant transformation of melanocytes. Although this usually occurs on the skin, it can arise in other locations where neural crest cells migrate such as the GI tract and brain.

Posted in: Medical Oncology17

Abstract | April 6, 2022

Non-Hodgkin’s lymphoma presenting as an ischemic stroke in a elderly male

Lymphoma is the most common blood cancer. The two main forms of lymphoma are Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) Marginal zone lymphomas (MZLs) are a group of indolent (slow- growing) B-cell NHLs, which account for approximately eight percent of all NHL cases.

Posted in: Geriatric Syndromes3 Medical Oncology17

Abstract | April 5, 2022

Gynecomastia with Dasatinib Use in Chronic Myeloid Leukemia

Gynecomastia is defined as enlargement of the glandular tissue in male breasts. Gynecomastia is an uncommon manifestation during treatment with a tyrosine kinase inhibitor, such as dasatinib or imatinib, with only a few reports of this occurrence. We describe a case highlighting this event and propose a potential treatment.

Posted in: Medical Oncology17

Abstract | April 4, 2022

HIV Stigma Among Male Homeless Patients in Student-run Clinics

Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) are major health issues within Louisiana. In 2018, Louisiana ranked 4th in the nation for both HIV and AIDS case rates.

Posted in: Oncologic Complications Of HIV Infection1

Abstract | April 4, 2022

Squamous Cell Carcinoma: 2021 Updated Review of Treatment

Squamous cell carcinoma (SCC) is the second most common cutaneous malignancy after basal cell carcinoma and has an increasing prevalence worldwide.

Posted in: Medical Oncology17

Abstract | April 4, 2022

Percutaneous Endoscopic Gastrostomy Seeding Metastatic Aerodigestive Cancer: A Fatal Complication of a Common Procedure

Percutaneous endoscopic gastrostomy (PEG) feeding is vital to maintain enteral nutrition during the treatment of head and neck cancers. PEG placement is a relatively safe procedure with low risk of complications.

Posted in: Medical Oncology17 Surgery & Surgical Specialties35

Abstract | May 5, 2021

Raising patient awareness of illnesses and vaccines through an educational video platform on head and neck cancers

Each year, more than 50,000 new cases of oropharyngeal cancers are diagnosed.1 Studies have shown that early detection and treatment can help improve patient outcomes. If the cancer is localized, the 5-year survival rate is 86% as compared to 36% in those with metastases.

Posted in: Medical Oncology17

Abstract | May 4, 2021

A Rare Complication of Breast Cancer Treatment: Radiation Induced Sarcoma

Sarcomas are a rare type of tumor that account for about one percent of all cancer, arises from mesenchymal cells, and are often asymptomatic until they become very large. Post-radiation sarcomas, or radiation induced sarcomas (RIS), are rare complications of radiotherapy that occur within a previously irradiated field over a latency period of 10 to 15 years.

Posted in: Medical Oncology17 Breast Cancer2

Abstract | November 13, 2020

Salvage Chemotherapy with Mini-CVD + Inotuzumab Ozogamicin in a Patient with Relapsed Extramedullary BCR-ABL Negative B-cell Acute Lymphoblastic Leukemia

Isolated extramedullary ALL relapse is rare and represents a challenging clinical scenario as patients with extramedullary disease are often excluded from clinical trials and there is limited data regarding optimal treatment strategies. Inotuzumab ozogamicin is a targeted therapy approved for relapsed ALL, and two case reports suggest extramedullary disease may respond to inotuzumab alone.

Posted in: Medical Oncology17 Medicine & Medical Specialties21

Abstract | November 13, 2020

Beyond The Barriers: A Case Series On Advanced Stage Breast and Gynecologic Cancer In New Orleans

Breast and gynecologic cancer screenings are available to a wide population of female patients through insurance providers and various support programs, however these cancers remain prevalent in our population today. In the context of screening availability, barriers leading to late/end-stage breast and gynecologic cancers must be explored. This report aims to highlight unique barriers that contribute to presentation with late-stage breast and gynecologic cancer in women of low socioeconomic status.

Posted in: Medical Oncology17 Women’s & Children’s Health27 Breast Cancer2 Gynecologic Cancer1

Load More Abstracts

SMA Menu